Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Type of arteriovenous vascular access and association with patency and mortality

Authors: Gürbey Ocak, Joris I Rotmans, Carla Y Vossen, Frits R Rosendaal, Raymond T Krediet, Elisabeth W Boeschoten, Friedo W Dekker, Marion Verduijn

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

There are only a few risk factors known for primary patency loss in patients with an arteriovenous graft or fistula. Furthermore, a limited number of studies have investigated the association between arteriovenous access modality and primary patency loss and mortality. The aim of this study was to investigate risk factors for patency loss and to investigate the association between graft versus fistula use and outcomes (patency loss and mortality).

Methods

We prospectively followed 919 incident hemodialysis patients and calculated hazard ratios (HRs) for putative risk factors of primary patency loss using Cox regression. Furthermore, HRs were calculated to study the association between graft versus fistula use and two-year primary patency loss and two-year mortality.

Results

Cardiovascular disease, prior catheter use, lowest tertile of albumin, highest tertile of hsCRP, and lowest tertile of fetuin-A were associated with primary patency loss in both patients with grafts and fistulas. Increased age, female sex, and diabetes mellitus were only associated with primary patency loss in patients with a fistula. We did not observe an association between primary patency loss and BMI, residual GFR, levels of calcium, phosphorus, and total cholesterol. Furthermore, graft use as compared with fistula use was associated with an 1.4-fold (95% CI 1.0-1.9) increased risk of primary patency loss and with an 1.5-fold(95% CI 1.0-2.2) increased mortality risk.

Conclusion

Cardiovascular disease, prior catheter use, albumin, hsCRP, and fetuin-A are risk factors for patency loss. Graft use as compared with fistula use was associated with an increased risk of patency loss and mortality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996, 7: 523-535.PubMed Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996, 7: 523-535.PubMed
2.
go back to reference U S Renal Data System: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2004, Bethesda, MD: USRDS 2004 Annual Data Report U S Renal Data System: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2004, Bethesda, MD: USRDS 2004 Annual Data Report
3.
go back to reference Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002, 62: 1109-1124. 10.1111/j.1523-1755.2002.kid551.x.CrossRefPubMed Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int. 2002, 62: 1109-1124. 10.1111/j.1523-1755.2002.kid551.x.CrossRefPubMed
4.
go back to reference Paszkowiak JJ, Dardik A: Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg. 2003, 37: 47-57. 10.1177/153857440303700107.CrossRefPubMed Paszkowiak JJ, Dardik A: Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg. 2003, 37: 47-57. 10.1177/153857440303700107.CrossRefPubMed
5.
go back to reference Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001, 59: 2325-2334.CrossRefPubMed Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001, 59: 2325-2334.CrossRefPubMed
6.
go back to reference Roy-Chaudhury P, Kelly BS, Zhang J, Narayana A, Desai P, Melham M, Duncan H, Heffelfinger SC: Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif. 2003, 21: 99-110. 10.1159/000067863.CrossRefPubMed Roy-Chaudhury P, Kelly BS, Zhang J, Narayana A, Desai P, Melham M, Duncan H, Heffelfinger SC: Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif. 2003, 21: 99-110. 10.1159/000067863.CrossRefPubMed
7.
go back to reference Chang CJ, Ko YS, Ko PJ, Hsu LA, Chen CF, Yang CW, Hsu TS, Pang JH: Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int. 2005, 68: 1312-1319. 10.1111/j.1523-1755.2005.00529.x.CrossRefPubMed Chang CJ, Ko YS, Ko PJ, Hsu LA, Chen CF, Yang CW, Hsu TS, Pang JH: Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int. 2005, 68: 1312-1319. 10.1111/j.1523-1755.2005.00529.x.CrossRefPubMed
8.
go back to reference Chang CJ, Ko PJ, Hsu LA, Ko YS, Ko YL, Chen CF, Huang CC, Hsu TS, Lee YS, Pang JH: Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004, 43: 74-84. 10.1053/j.ajkd.2003.09.015.CrossRefPubMed Chang CJ, Ko PJ, Hsu LA, Ko YS, Ko YL, Chen CF, Huang CC, Hsu TS, Lee YS, Pang JH: Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004, 43: 74-84. 10.1053/j.ajkd.2003.09.015.CrossRefPubMed
9.
go back to reference Rotmans JI, Pasterkamp G, Verhagen HJ, Pattynama PM, Blankestijn PJ, Stroes ES: Hemodialysis access graft failure: time to revisit an unmet clinical need?. J Nephrol. 2005, 18: 9-20.PubMed Rotmans JI, Pasterkamp G, Verhagen HJ, Pattynama PM, Blankestijn PJ, Stroes ES: Hemodialysis access graft failure: time to revisit an unmet clinical need?. J Nephrol. 2005, 18: 9-20.PubMed
10.
go back to reference Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005, 16: 1449-1455. 10.1681/ASN.2004090748.CrossRefPubMed Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005, 16: 1449-1455. 10.1681/ASN.2004090748.CrossRefPubMed
11.
go back to reference Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001, 60: 1443-1451. 10.1046/j.1523-1755.2001.00947.x.CrossRefPubMed Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001, 60: 1443-1451. 10.1046/j.1523-1755.2001.00947.x.CrossRefPubMed
12.
go back to reference Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet RT, Dekker FW: Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int. 2007, 72: 202-207. 10.1038/sj.ki.5002178.CrossRefPubMed Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Boeschoten EW, Leunissen KM, Krediet RT, Dekker FW: Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int. 2007, 72: 202-207. 10.1038/sj.ki.5002178.CrossRefPubMed
13.
go back to reference van Stralen KJ, Dekker FW, Zoccali C, Jager KJ: Confounding. Nephron Clin Pract. 2010, 116: c143-c147. 10.1159/000315883.CrossRefPubMed van Stralen KJ, Dekker FW, Zoccali C, Jager KJ: Confounding. Nephron Clin Pract. 2010, 116: c143-c147. 10.1159/000315883.CrossRefPubMed
14.
go back to reference Ocak G, Halbesma N, le CS, Hoogeveen EK, van DS, Kooman J, Dekker FW, Krediet RT, Boeschoten EW, Verduijn M: Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients. Nephrol Dial Transplant. 2011, Ocak G, Halbesma N, le CS, Hoogeveen EK, van DS, Kooman J, Dekker FW, Krediet RT, Boeschoten EW, Verduijn M: Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients. Nephrol Dial Transplant. 2011,
15.
go back to reference Van Dijk PC, Jager KJ, De CF, Collart F, Cornet R, Dekker FW, Gronhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD: Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001, 16: 1120-1129. 10.1093/ndt/16.6.1120.CrossRefPubMed Van Dijk PC, Jager KJ, De CF, Collart F, Cornet R, Dekker FW, Gronhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD: Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant. 2001, 16: 1120-1129. 10.1093/ndt/16.6.1120.CrossRefPubMed
16.
go back to reference Monroy-Cuadros M, Yilmaz S, Salazar-Banuelos A, Doig C: Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol. 2010, 5: 1787-1792. 10.2215/CJN.09441209.CrossRefPubMedPubMedCentral Monroy-Cuadros M, Yilmaz S, Salazar-Banuelos A, Doig C: Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol. 2010, 5: 1787-1792. 10.2215/CJN.09441209.CrossRefPubMedPubMedCentral
17.
go back to reference Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Lai CF, Yang JY, Peng YS, Tsai TJ, Wu KD: Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 2010, 56: 720-727. 10.1053/j.ajkd.2010.06.015.CrossRefPubMed Chen HY, Chiu YL, Chuang YF, Hsu SP, Pai MF, Lai CF, Yang JY, Peng YS, Tsai TJ, Wu KD: Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 2010, 56: 720-727. 10.1053/j.ajkd.2010.06.015.CrossRefPubMed
18.
go back to reference Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M: Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis. 2000, 36: 68-74. 10.1053/ajkd.2000.8269.CrossRefPubMed Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M: Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis. 2000, 36: 68-74. 10.1053/ajkd.2000.8269.CrossRefPubMed
19.
go back to reference Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ: Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008, 3: 714-719. 10.2215/CJN.02950707.CrossRefPubMedPubMedCentral Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ: Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008, 3: 714-719. 10.2215/CJN.02950707.CrossRefPubMedPubMedCentral
20.
go back to reference Prischl FC, Kirchgatterer A, Brandstatter E, Wallner M, Baldinger C, Roithinger FX, Kramar R: Parameters of prognostic relevance to the patency of vascular access in hemodialysis patients. J Am Soc Nephrol. 1995, 6: 1613-1618.PubMed Prischl FC, Kirchgatterer A, Brandstatter E, Wallner M, Baldinger C, Roithinger FX, Kramar R: Parameters of prognostic relevance to the patency of vascular access in hemodialysis patients. J Am Soc Nephrol. 1995, 6: 1613-1618.PubMed
21.
go back to reference Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL: Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg. 1997, 26: 1009-1019. 10.1016/S0741-5214(97)70014-4.CrossRefPubMed Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL: Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg. 1997, 26: 1009-1019. 10.1016/S0741-5214(97)70014-4.CrossRefPubMed
22.
go back to reference Erkut B, Unlu Y, Ceviz M, Becit N, Ates A, Colak A, Kocak H: Primary arteriovenous fistulas in the forearm for hemodialysis: effect of miscellaneous factors in fistula patency. Ren Fail. 2006, 28: 275-281. 10.1080/08860220600583617.CrossRefPubMed Erkut B, Unlu Y, Ceviz M, Becit N, Ates A, Colak A, Kocak H: Primary arteriovenous fistulas in the forearm for hemodialysis: effect of miscellaneous factors in fistula patency. Ren Fail. 2006, 28: 275-281. 10.1080/08860220600583617.CrossRefPubMed
23.
go back to reference Ifudu O, Mayers JD, Cohen LS, Paul H, Brezsnyak WF, Avram MM, Herman AI, Friedman EA: Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients. Am J Nephrol. 1996, 16: 118-123. 10.1159/000168982.CrossRefPubMed Ifudu O, Mayers JD, Cohen LS, Paul H, Brezsnyak WF, Avram MM, Herman AI, Friedman EA: Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients. Am J Nephrol. 1996, 16: 118-123. 10.1159/000168982.CrossRefPubMed
24.
go back to reference Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003, 361: 827-833. 10.1016/S0140-6736(03)12710-9.CrossRefPubMed Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003, 361: 827-833. 10.1016/S0140-6736(03)12710-9.CrossRefPubMed
25.
go back to reference Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimburger O, Holmes C, Schalling M, Nordfors L: Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005, 67: 2383-2392. 10.1111/j.1523-1755.2005.00345.x.CrossRefPubMed Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimburger O, Holmes C, Schalling M, Nordfors L: Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005, 67: 2383-2392. 10.1111/j.1523-1755.2005.00345.x.CrossRefPubMed
26.
go back to reference Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006, 47: 139-148. 10.1053/j.ajkd.2005.09.014.CrossRefPubMed Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006, 47: 139-148. 10.1053/j.ajkd.2005.09.014.CrossRefPubMed
27.
go back to reference Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry MJ, El-Khatib M, Banerjee R, Munda R, Roy-Chaudhury P: Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant. 2011, 26: 2264-2270. 10.1093/ndt/gfq733.CrossRefPubMedPubMedCentral Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry MJ, El-Khatib M, Banerjee R, Munda R, Roy-Chaudhury P: Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant. 2011, 26: 2264-2270. 10.1093/ndt/gfq733.CrossRefPubMedPubMedCentral
28.
go back to reference Hansson GK: Atherosclerosis–an immune disease: The Anitschkov Lecture 2007. Atherosclerosis. 2009, 202: 2-10. 10.1016/j.atherosclerosis.2008.08.039.CrossRefPubMed Hansson GK: Atherosclerosis–an immune disease: The Anitschkov Lecture 2007. Atherosclerosis. 2009, 202: 2-10. 10.1016/j.atherosclerosis.2008.08.039.CrossRefPubMed
29.
go back to reference Hansson GK, Jonasson L, Lojsthed B, Stemme S, Kocher O, Gabbiani G: Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis. 1988, 72: 135-141. 10.1016/0021-9150(88)90074-3.CrossRefPubMed Hansson GK, Jonasson L, Lojsthed B, Stemme S, Kocher O, Gabbiani G: Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis. 1988, 72: 135-141. 10.1016/0021-9150(88)90074-3.CrossRefPubMed
30.
go back to reference Allon M, Lok CE: Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol. 2010, 5: 2348-2354. 10.2215/CJN.06050710.CrossRefPubMed Allon M, Lok CE: Dialysis fistula or graft: the role for randomized clinical trials. Clin J Am Soc Nephrol. 2010, 5: 2348-2354. 10.2215/CJN.06050710.CrossRefPubMed
31.
go back to reference NKF-KDOQI clinical practice guidelines for vascular access: National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1997, 30: S150-S191. NKF-KDOQI clinical practice guidelines for vascular access: National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1997, 30: S150-S191.
Metadata
Title
Type of arteriovenous vascular access and association with patency and mortality
Authors
Gürbey Ocak
Joris I Rotmans
Carla Y Vossen
Frits R Rosendaal
Raymond T Krediet
Elisabeth W Boeschoten
Friedo W Dekker
Marion Verduijn
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-79

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.